In SPG4 and other slowly progressive neurodegenerative diseases, the effect of slow disease‐related axonal loss is probably weighed out by the rising age‐related release of sNfL, altogether leading to a comparatively low increase in sNfL levels in aging patients. The gene discussed is SPAST; the disease is neurodegenerative disease.